Zhong Zhaohui, Gu Huiying, Peng Jirun, Wang Wenzheng, Johnstone Brian H, March Keith L, Farlow Martin R, Du Yansheng
Department of General Surgery, Peking University People's Hospital, Beijing 100044, PR China.
Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Oncotarget. 2016 Jun 14;7(24):36829-36841. doi: 10.18632/oncotarget.9208.
Adipose tissue stroma contains a population of mesenchymal stem cells (MSC) promote new blood vessel formation and stabilization. These adipose-derived stem cells (ASC) promote de novo formation of vascular structures in vitro. We investigated the angiogenic factors secreted by ASC and discovered that glial-derived neurotrophic factor (GDNF) is a key mediator for endothelial cell network formation. It was found that both GDNF alone or present in ASC-conditioned medium (ASC-CM) stimulated capillary network formation by using human umbilical vein endothelial cells (HUVECs) and such an effect was totally independent of vascular endothelial growth factor (VEGF) activity. Additionally, we showed stimulation of capillary network formation by GDNF, but not VEGF, could be blocked by the Ret (rearranged during transfection) receptor antagonist RPI-1, a GDNF signaling inhibitor. Furthermore, GDNF were found to be overexpressed in cancer cells that were resistant to the anti-angiogenic treatment using the VEGF antibody. Cancer cells in the liver hepatocellular carcinoma (HCC), a non-nervous related cancer, highly overexpressed GDNF as compared to normal liver cells. Our data strongly suggest that, in addition to VEGF, GDNF secreted by ASC and HCC cells, may be another important factor promoting pathological neovascularization. Thus, GDNF may be a potential therapeutic target for HCC and obesity treatments.
脂肪组织基质包含一群间充质干细胞(MSC),可促进新血管的形成和稳定。这些脂肪来源的干细胞(ASC)在体外促进血管结构的从头形成。我们研究了ASC分泌的血管生成因子,发现胶质细胞源性神经营养因子(GDNF)是内皮细胞网络形成的关键介质。研究发现,单独的GDNF或存在于ASC条件培养基(ASC-CM)中的GDNF,均可通过人脐静脉内皮细胞(HUVEC)刺激毛细血管网络的形成,且这种作用完全独立于血管内皮生长因子(VEGF)的活性。此外,我们发现GDNF而非VEGF刺激毛细血管网络形成的作用,可被Ret(转染时重排)受体拮抗剂RPI-1(一种GDNF信号抑制剂)阻断。此外,在对使用VEGF抗体的抗血管生成治疗有抗性的癌细胞中,发现GDNF过表达。在肝细胞癌(HCC)(一种与神经无关的癌症)中,癌细胞与正常肝细胞相比,GDNF高度过表达。我们的数据强烈表明,除了VEGF外,ASC和HCC细胞分泌的GDNF可能是促进病理性新血管形成的另一个重要因素。因此,GDNF可能是HCC和肥胖症治疗的潜在治疗靶点。